| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $54.3M | -0.8% | +53.9% |
| Cost of Revenue | $26.3M | -8.1% | +49.7% |
| Gross Profit | $28.0M | +7.2% | +58.2% |
| R&D Expense | $42.8M | -0.9% | -16.1% |
| SG&A Expense | $21.7M | -13.8% | -12.6% |
| Operating Income | -$45.9M | +13.1% | +32.8% |
| Pre-tax Income | -$32.6M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $172.1M | -21.7% | +7.3% |
| Short-term Investments | $219.1M | -4.9% | -4.0% |
| Accounts Receivable | $29.4M | +191.7% | +121.2% |
| Current Assets | $471.7M | -8.2% | +3.4% |
| Total Assets | $653.7M | -5.0% | -2.3% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $30.0M | — | — |
| Capital Expenditures | $1.4M | — | — |
| Investing Cash Flow | -$13.5M | — | — |
| Financing Cash Flow | $2.7M | — | — |
| Free Cash Flow | $28.6M | — | — |
| +23.9% |
| +14.6% |
| Income Tax | $162K | -43.6% | +280.0% |
| Net Income | -$32.8M | +24.0% | +14.0% |
| EPS (Basic) | -$0.45 | +23.7% | +13.5% |
| EPS (Diluted) | -$0.45 | +23.7% | +13.5% |
| $145.1M |
| -6.8% |
| +30.6% |
| Total Liabilities | $332.3M | -3.8% | +51.1% |
| Stockholders' Equity | $321.4M | -6.3% | -28.5% |